{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:12:40Z","timestamp":1792692760909,"version":"4.5.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,11,14]],"date-time":"2013-11-14T00:00:00Z","timestamp":1384387200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Mumps virus (MuV) is a highly infectious paramyxovirus closely related to measles virus (MeV). Despite the availability of a mumps vaccine, outbreaks continue to occur and no treatment options are available. Vitamin A and other naturally occurring retinoids inhibit the replication of MeV<jats:italic>in vitro<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Anti-viral effects of retinoids were observed in cell culture using the myelomonocytic U937, NB4\/R4, and Huh7\/7.5 cells. Observations of anti-viral effect were quantified using TCID50 analysis. Molecular properties of the antiviral effect were analysed using quantitative RT-PCR and western blot.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The current work demonstrates that retinoids inhibit MuV<jats:italic>in vitro<\/jats:italic>due to up-regulation of type I interferon (IFN) and IFN stimulated genes. This effect is mediated by nuclear retinoid receptor signalling and RIG-I is required. The antiviral retinoid-induced state makes cells less permissive to viral replication from subsequent challenge with either MuV or MeV for less than 12 hours.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>These results demonstrate that retinoids inhibit MuV replication in uninfected bystander cells through a retinoid inducible gene I (RIG-I), retinoic acid receptor (RAR) and IFN dependent manner making them refractory to subsequent rounds of viral replication. These observations raise the possibility that pharmacological doses of retinoids might have clinical benefit in MuV infection.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1743-422x-10-337","type":"journal-article","created":{"date-parts":[[2013,11,14]],"date-time":"2013-11-14T08:01:29Z","timestamp":1384416089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["In vitro inhibition of mumps virus by retinoids"],"prefix":"10.1186","volume":"10","author":[{"given":"Kaitlin J","family":"Soye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Trottier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Z","family":"Di Lenardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine H","family":"Restori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Reichman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Wilson H","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,14]]},"reference":[{"key":"2317_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1089\/jir.2009.0071","volume":"29","author":"S Goodbourn","year":"2009","unstructured":"Goodbourn S, Randall RE: The regulation of type i interferon production by paramyxoviruses. J Interferon Cytokine Res 2009, 29: 539-548. 10.1089\/jir.2009.0071","journal-title":"J Interferon Cytokine Res"},{"key":"2317_CR2","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/S0140-6736(08)60419-5","volume":"371","author":"A Hviid","year":"2008","unstructured":"Hviid A, Rubin S, Muhlemann K: Mumps. Lancet 2008, 371: 932-944. 10.1016\/S0140-6736(08)60419-5","journal-title":"Lancet"},{"key":"2317_CR3","volume-title":"WHO-recommended standards for surveillance of selected vaccine-preventable diseases","author":"WHO","year":"2003","unstructured":"WHO: WHO-recommended standards for surveillance of selected vaccine-preventable diseases. Geneva, Switzerland: Biologicals VAaMTotDoVa ed; 2003."},{"key":"2317_CR4","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1128\/JCM.00434-10","volume":"48","author":"MJ Carr","year":"2010","unstructured":"Carr MJ, Moss E, Waters A, Dean J, Jin L, Coughlan S, Connell J, Hall WW, Hassan J: Molecular epidemiological evaluation of the recent resurgence in mumps virus infections in Ireland. J Clin Microbiol 2010, 48: 3288-3294. 10.1128\/JCM.00434-10","journal-title":"J Clin Microbiol"},{"key":"2317_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/ese.15.23.19586-en","volume":"15","author":"G Kuzmanovska","year":"2010","unstructured":"Kuzmanovska G, Polozhani A, Mikik V, Stavridis K, Aleksoski B, Cvetanovska Z, Binnendijk R, Bosevska G: Mumps outbreak in the former Yugoslav republic of macedonia, january 2008-June 2009: epidemiology and control measures. Euro Surveill 2010, 15: 1-9.","journal-title":"Euro Surveill"},{"key":"2317_CR6","first-page":"15","volume":"2010","author":"J Whelan","year":"2010","unstructured":"Whelan J, van Binnendijk R, Greenland K, Fanoy E, Khargi M, Yap K, Boot H, Veltman N, Swaan C, van der Bij A, et al.: Ongoing mumps outbreak in a student population with high vaccination coverage, Netherlands, 2010. Euro Surveill 2010, 2010: 15.","journal-title":"Euro Surveill"},{"key":"2317_CR7","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3201\/eid1603.090198","volume":"16","author":"AL Bonebrake","year":"2010","unstructured":"Bonebrake AL, Silkaitis C, Monga G, Galat A, Anderson J, Trad JT, Hedley K, Burgess N, Zembower TR: Effects of mumps outbreak in hospital, Chicago, Illinois, USA, 2006. Emerg Infect Dis 2010, 16: 426-432. 10.3201\/eid1603.090198","journal-title":"Emerg Infect Dis"},{"key":"2317_CR8","first-page":"1321","volume":"58","author":"CDC","year":"2009","unstructured":"CDC: Global measles mortality, 2000\u20132008. MMWR Morb Mortal Wkly Rep 2009, 58: 1321-1326.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2317_CR9","first-page":"125","volume":"59","author":"CDC","year":"2010","unstructured":"CDC: Update: mumps outbreak - New York and New Jersey, June 2009-January 2010. MMWR Morb Mortal Wkly Rep 2010, 59: 125-129.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2317_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/ese.14.50.19440-en","volume":"14","author":"C Stein-Zamir","year":"2009","unstructured":"Stein-Zamir C, Shoob H, Abramson N, Tallen-Gozani E, Sokolov I, Zentner G: Mumps outbreak in Jerusalem affecting mainly male adolescents. Euro Surveill 2009, 14: 1-3.","journal-title":"Euro Surveill"},{"key":"2317_CR11","doi-asserted-by":"crossref","first-page":"398","DOI":"10.5694\/j.1326-5377.2009.tb02850.x","volume":"191","author":"RD Bangor-Jones","year":"2009","unstructured":"Bangor-Jones RD, Dowse GK, Giele CM, van Buynder PG, Hodge MM, Whitty MM: A prolonged mumps outbreak among highly vaccinated Aboriginal people in the Kimberley region of Western Australia. Med J Aust 2009, 191: 398-401.","journal-title":"Med J Aust"},{"key":"2317_CR12","first-page":"14","volume":"2009","author":"C Roberts","year":"2009","unstructured":"Roberts C, Porter-Jones G, Crocker J, Hart J: Mumps outbreak on the island of Anglesey, North Wales, December 2008-January, 2009. Euro Surveill 2009, 2009: 14.","journal-title":"Euro Surveill"},{"key":"2317_CR13","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/S0140-6736(86)91157-8","volume":"1","author":"A Sommer","year":"1986","unstructured":"Sommer A, Tarwotjo I, Djunaedi E, West KP Jr, Loeden AA, Tilden R, Mele L: Impact of vitamin A supplementation on childhood mortality: A randomised controlled community trial. Lancet 1986, 1: 1169-1173.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"2317_CR14","doi-asserted-by":"publisher","first-page":"S122","DOI":"10.1086\/315921","volume":"182","author":"E Villamor","year":"2000","unstructured":"Villamor E, Fawzi WW: Vitamin A supplementation: implications for morbidity and mortality in children. J Infect Dis 2000,182(Suppl 1):S122-S133.","journal-title":"J Infect Dis"},{"key":"2317_CR15","first-page":"1","volume-title":"Cochrane Database Syst Rev","author":"A Imdad","year":"2010","unstructured":"Imdad A, Herzer K, Mayo-Wilson E, Yakoob MY, Bhutta ZA: Vitamin A supplementation for preventing morbidity and mortality in children from 6\u00a0months to 5\u00a0years of age. Cochrane Database Syst Rev 2010, 1-27. (CD008524)"},{"key":"2317_CR16","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1136\/bmj.294.6567.294","volume":"294","author":"AJ Barclay","year":"1987","unstructured":"Barclay AJ, Foster A, Sommer A: Vitamin A supplements and mortality related to measles: a randomised clinical trial. Br Med J 1987, 294: 294-296. 10.1136\/bmj.294.6567.294","journal-title":"Br Med J"},{"key":"2317_CR17","first-page":"1","volume-title":"Cochrane Database Syst Rev","author":"Y Huiming","year":"2005","unstructured":"Huiming Y, Chaomin W, Meng M: Vitamin A for treating measles in children. Cochrane Database Syst Rev 2005, 1-2. (CD001479)"},{"key":"2317_CR18","first-page":"1","volume-title":"Cochrane Database Syst Rev","author":"HM Yang","year":"2005","unstructured":"Yang HM, Mao M, Wan C: Vitamin A for treating measles in children. Cochrane Database Syst Rev 2005, 1-38. (CD001479)"},{"key":"2317_CR19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/tropej\/48.6.323","volume":"48","author":"RM D\u2019Souza","year":"2002","unstructured":"D\u2019Souza RM, D\u2019Souza R: Vitamin A for the treatment of children with measles\u2013a systematic review. J Trop Pediatr 2002, 48: 323-327. 10.1093\/tropej\/48.6.323","journal-title":"J Trop Pediatr"},{"key":"2317_CR20","first-page":"21","volume":"35","author":"WHO\/UNICEF","year":"1988","unstructured":"WHO\/UNICEF: Joint WHO\/UNICEF statement on vitamin A for measles. Int Nurs Rev 1988, 35: 21.","journal-title":"Int Nurs Rev"},{"key":"2317_CR21","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/neu.20242","volume":"66","author":"R Blomhoff","year":"2006","unstructured":"Blomhoff R, Blomhoff HK: Overview of retinoid metabolism and function. J Neurobiol 2006, 66: 606-630. 10.1002\/neu.20242","journal-title":"J Neurobiol"},{"key":"2317_CR22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0079-6603(08)60722-9","volume":"63","author":"JL Napoli","year":"1999","unstructured":"Napoli JL: Retinoic acid: its biosynthesis and metabolism. Prog Nucleic Acid Res Mol Biol 1999, 63: 139-188.","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"2317_CR23","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nri2378","volume":"8","author":"JR Mora","year":"2008","unstructured":"Mora JR, Iwata M, von Andrian UH: Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 2008, 8: 685-698. 10.1038\/nri2378","journal-title":"Nat Rev Immunol"},{"key":"2317_CR24","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1124\/pr.58.4.4","volume":"58","author":"P Germain","year":"2006","unstructured":"Germain P, Chambon P, Eichele G, Evans RM, Lazar MA, Leid M, De Lera AR, Lotan R, Mangelsdorf DJ, Gronemeyer H: International union of pharmacology. LX. Retinoic acid receptors. Pharmacol Rev 2006, 58: 712-725. 10.1124\/pr.58.4.4","journal-title":"Pharmacol Rev"},{"key":"2317_CR25","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1038\/sj.emboj.7600302","volume":"23","author":"N Clarke","year":"2004","unstructured":"Clarke N, Jimenez-Lara AM, Voltz E, Gronemeyer H: Tumor suppressor IRF-1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL. EMBO J 2004, 23: 3051-3060. 10.1038\/sj.emboj.7600302","journal-title":"EMBO J"},{"key":"2317_CR26","doi-asserted-by":"publisher","first-page":"10508","DOI":"10.1074\/jbc.271.18.10508","volume":"271","author":"V Kolla","year":"1996","unstructured":"Kolla V, Lindner DJ, Xiao W, Borden EC, Kalvakolanu DV: Modulation of interferon (IFN)-inducible gene expression by retinoic acid: Up-regulation of STAT1 protein in IFN-unresponsive cells. J Biol Chem 1996, 271: 10508-10514. 10.1074\/jbc.271.18.10508","journal-title":"J Biol Chem"},{"key":"2317_CR27","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/clinids\/19.3.489","volume":"19","author":"RD Semba","year":"1994","unstructured":"Semba RD: Vitamin A, immunity, and infection. Clin Infect Dis 1994, 19: 489-499. 10.1093\/clinids\/19.3.489","journal-title":"Clin Infect Dis"},{"key":"2317_CR28","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.it.2006.06.003","volume":"27","author":"EM Creagh","year":"2006","unstructured":"Creagh EM, O\u2019Neill LA: TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol 2006, 27: 352-357. 10.1016\/j.it.2006.06.003","journal-title":"Trends Immunol"},{"key":"2317_CR29","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.immuni.2006.08.014","volume":"25","author":"AH van Boxel-Dezaire","year":"2006","unstructured":"van Boxel-Dezaire AH, Rani MR, Stark GR: Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 2006, 25: 361-372. 10.1016\/j.immuni.2006.08.014","journal-title":"Immunity"},{"key":"2317_CR30","first-page":"263","volume":"10","author":"ZA Percario","year":"1999","unstructured":"Percario ZA, Giandomenico V, Fiorucci G, Chiantore MV, Vannucchi S, Hiscott J, Affabris E, Romeo G: Retinoic acid is able to induce interferon regulatory factor 1 in squamous carcinoma cells via a STAT-1 independent signalling pathway. Cell Growth Differ 1999, 10: 263-270.","journal-title":"Cell Growth Differ"},{"key":"2317_CR31","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.1038\/sj.onc.1202802","volume":"18","author":"L Pelicano","year":"1999","unstructured":"Pelicano L, Brumpt C, Pitha PM, Chelbi-Alix MK: Retinoic acid resistance in NB4 APL cells is associated with lack of interferon alpha synthesis Stat1 and p48 induction. Oncogene 1999, 18: 3944-3953. 10.1038\/sj.onc.1202802","journal-title":"Oncogene"},{"key":"2317_CR32","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1038\/sj.onc.1201410","volume":"15","author":"L Pelicano","year":"1997","unstructured":"Pelicano L, Li F, Schindler C, Chelbi-Alix MK: Retinoic acid enhances the expression of interferon-induced proteins: evidence for multiple mechanisms of action. Oncogene 1997, 15: 2349-2359. 10.1038\/sj.onc.1201410","journal-title":"Oncogene"},{"key":"2317_CR33","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1182\/blood.V88.1.114.114","volume":"88","author":"S Matikainen","year":"1996","unstructured":"Matikainen S, Ronni T, Hurme M, Pine R, Julkunen I: Retinoic acid activates interferon regulatory factor-1 gene expression in myeloid cells. Blood 1996, 88: 114-123.","journal-title":"Blood"},{"key":"2317_CR34","doi-asserted-by":"publisher","first-page":"36228","DOI":"10.1074\/jbc.M505749200","volume":"280","author":"XM Luo","year":"2005","unstructured":"Luo XM, Ross AC: Physiological and receptor-selective retinoids modulate interferon \u03b3 signaling by increasing the expression, nuclear localization, and functional activity of interferon regulatory factor-1. J Biol Chem 2005, 280: 36228-36236. 10.1074\/jbc.M505749200","journal-title":"J Biol Chem"},{"key":"2317_CR35","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1177\/153537020623100517","volume":"231","author":"XM Luo","year":"2006","unstructured":"Luo XM, Ross AC: Retinoic acid exerts dual regulatory actions on the expression and nuclear localization of interferon regulatory factor-1. Exp Biol Med 2006, 231: 619-631.","journal-title":"Exp Biol Med"},{"key":"2317_CR36","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1182\/blood.V96.4.1496","volume":"96","author":"TX Liu","year":"2000","unstructured":"Liu TX, Zhang JW, Tao J, Zhang RB, Zhang QH, Zhao CJ, Tong JH, Lanotte M, Waxman S, Chen SJ, et al.: Gene expression networks underlying retinoic acid-induced differentiation of acute promyelocytic leukemia cells. Blood 2000, 96: 1496-1504.","journal-title":"Blood"},{"key":"2317_CR37","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1182\/blood.V89.3.1001","volume":"89","author":"M Gianni","year":"1997","unstructured":"Gianni M, Terao M, Fortino I, LiCalzi M, Viggiano V, Barbui T, Rambaldi A, Garattini E: Stat1 is induced and activated by all-trans retinoic acid in acute promyelocytic leukemia cells. Blood 1997, 89: 1001-1012.","journal-title":"Blood"},{"key":"2317_CR38","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1182\/blood.V96.8.2870","volume":"96","author":"A Dimberg","year":"2000","unstructured":"Dimberg A, Nilsson K, Oberg F: Phosphorylation-deficient Stat1 inhibits retinoic acid-induced differentiation and cell cycle arrest in U-937 monoblasts. Blood 2000, 96: 2870-2878.","journal-title":"Blood"},{"key":"2317_CR39","first-page":"1102","volume":"9","author":"I Arany","year":"2002","unstructured":"Arany I, Whitehead WE, Grattendick KJ, Ember IA, Tyring SK: Suppression of growth by all-trans retinoic acid requires prolonged induction of interferon regulatory factor 1 in cervical squamous carcinoma (SiHa) cells. Clin Diagn Lab Immunol 2002, 9: 1102-1106.","journal-title":"Clin Diagn Lab Immunol"},{"key":"2317_CR40","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1371\/journal.pone.0000279","volume":"2","author":"S Plumet","year":"2007","unstructured":"Plumet S, Herschke F, Bourhis J-M, Valentin H, Longhi S, Gerlier D: Cytosolic 5\u2019-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon response. PLoS ONE 2007, 2: e279. 10.1371\/journal.pone.0000279","journal-title":"PLoS ONE"},{"key":"2317_CR41","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1126\/science.1132998","volume":"314","author":"A Pichlmair","year":"2006","unstructured":"Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F: Reis e Sousa C: RIG-I-mediated antiviral responses to single-stranded RNA bearing 5\u2019-phosphates. Science 2006, 314: 997-1001. 10.1126\/science.1132998","journal-title":"Science"},{"key":"2317_CR42","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1126\/science.1132505","volume":"314","author":"V Hornung","year":"2006","unstructured":"Hornung V, Ellegast J, Kim S, Brzozka K, Jung A, Kato H, Poeck H, Akira S, Conzelmann KK, Schlee M, et al.: 5\u2019-Triphosphate RNA is the ligand for RIG-I. Science 2006, 314: 994-997. 10.1126\/science.1132505","journal-title":"Science"},{"key":"2317_CR43","doi-asserted-by":"publisher","first-page":"12067","DOI":"10.1073\/pnas.0900971106","volume":"106","author":"A Schmidt","year":"2009","unstructured":"Schmidt A, Schwerd T, Hamm W, Hellmuth JC, Cui S, Wenzel M, Hoffmann FS, Michallet MC, Besch R, Hopfner KP, et al.: 5\u2019-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. Proc Natl Acad Sci U S A 2009, 106: 12067-12072. 10.1073\/pnas.0900971106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2317_CR44","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/ni1087","volume":"5","author":"M Yoneyama","year":"2004","unstructured":"Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T: The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004, 5: 730-737. 10.1038\/ni1087","journal-title":"Nat Immunol"},{"key":"2317_CR45","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/jcp.21128","volume":"213","author":"ZZ Su","year":"2007","unstructured":"Su ZZ, Sarkar D, Emdad L, Barral PM, Fisher PB: Central role of interferon regulatory factor-1 (IRF-1) in controlling retinoic acid inducible gene-I (RIG-I) expression. J Cell Physiol 2007, 213: 502-510. 10.1002\/jcp.21128","journal-title":"J Cell Physiol"},{"key":"2317_CR46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.antiviral.2008.04.003","volume":"80","author":"C Trottier","year":"2008","unstructured":"Trottier C, Chabot S, Mann KK, Colombo M, Chatterjee A: Miller Jr WH, Ward BJ: Retinoids inhibit measles virus in vitro via nuclear retinoid receptor signaling pathways. Antiviral Res 2008, 80: 45-53. 10.1016\/j.antiviral.2008.04.003","journal-title":"Antiviral Res"},{"key":"2317_CR47","doi-asserted-by":"publisher","first-page":"e22323","DOI":"10.1371\/journal.pone.0022323","volume":"6","author":"KJ Soye","year":"2011","unstructured":"Soye KJ, Trottier C, Richardson CD, Ward BJ, Miller WH Jr: RIG-I Is Required for the Inhibition of Measles Virus by Retinoids. PloS one 2011, 6: e22323. 10.1371\/journal.pone.0022323","journal-title":"PloS one"},{"key":"2317_CR48","volume-title":"FASEB J","author":"C Trottier","year":"2009","unstructured":"Trottier C, Colombo M, Mann KK, Miller WH Jr, Ward BJ: Retinoids inhibit measles virus through a type I IFN-dependent bystander effect. FASEB J 2009. fj.09-129288"},{"key":"2317_CR49","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/jlb.37.4.407","volume":"37","author":"P Harris","year":"1985","unstructured":"Harris P, Ralph P: Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines. J Leukoc Biol 1985, 37: 407-422.","journal-title":"J Leukoc Biol"},{"key":"2317_CR50","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/j.1348-0421.1996.tb01141.x","volume":"40","author":"N Fujii","year":"1996","unstructured":"Fujii N, Yokosawa N, Ishida S, Shirakawa S, Kubota T, Indoh T, Fujinaga K, Yashiki T: Investigation of IFN type-I receptor and IFN regulatory factor expression relating to induction of 2\u2019\u2009, 5\u2019-oligoadenylate synthetase in cells persistently infected with the mumps virus. Microbiol Immunol 1996, 40: 777-781. 10.1111\/j.1348-0421.1996.tb01141.x","journal-title":"Microbiol Immunol"},{"key":"2317_CR51","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1348-0421.1996.tb01127.x","volume":"40","author":"T Indoh","year":"1996","unstructured":"Indoh T, Shirakawa S, Kubota T, Yashiki T, Isogai E, Fujii N: Augmentation of interferon production after cell-differentiation of U937 cells by TPA. Microbiol Immunol 1996, 40: 675-679. 10.1111\/j.1348-0421.1996.tb01127.x","journal-title":"Microbiol Immunol"},{"key":"2317_CR52","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/j.1348-0421.2000.tb02531.x","volume":"44","author":"Y Hariya","year":"2000","unstructured":"Hariya Y, Yokosawa N, Yonekura N, Kohama G, Fuji N: Mumps virus can suppress the effective augmentation of HPC-induced apoptosis by IFN-gamma through disruption of IFN signaling in U937 cells. Microbiol Immunol 2000, 44: 537-541. 10.1111\/j.1348-0421.2000.tb02531.x","journal-title":"Microbiol Immunol"},{"issue":"Suppl 3","key":"2317_CR53","first-page":"S1","volume":"8","author":"SM Pemrick","year":"1994","unstructured":"Pemrick SM, Lucas DA, Grippo JF: The retinoid receptors. Leukemia 1994,8(Suppl 3):S1-S10.","journal-title":"Leukemia"},{"key":"2317_CR54","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1182\/blood.V89.12.4282","volume":"89","author":"W Shao","year":"1997","unstructured":"Shao W, Benedetti L, Lamph WW, Nervi C, Miller WH Jr: A Retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RARalpha mutation. Blood 1997, 89: 4282-4289.","journal-title":"Blood"},{"key":"2317_CR55","doi-asserted-by":"publisher","first-page":"7186","DOI":"10.1038\/sj.onc.1204766","volume":"20","author":"A Zelent","year":"2001","unstructured":"Zelent A, Guidez F, Melnick A, Waxman S, Licht JD: Translocations of the RARalpha gene in acute promyelocytic leukemia. Oncogene 2001, 20: 7186-7203. 10.1038\/sj.onc.1204766","journal-title":"Oncogene"},{"key":"2317_CR56","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1126\/science.290.5498.1972","volume":"290","author":"KJ Blight","year":"2000","unstructured":"Blight KJ, Kolykhalov AA, Rice CM: Efficient Initiation of HCV RNA replication in cell culture. Science 2000, 290: 1972-1974. 10.1126\/science.290.5498.1972","journal-title":"Science"},{"key":"2317_CR57","doi-asserted-by":"publisher","first-page":"13001","DOI":"10.1128\/JVI.76.24.13001-13014.2002","volume":"76","author":"KJ Blight","year":"2002","unstructured":"Blight KJ, McKeating JA, Rice CM: Highly permissive cell lines for subgenomic and genomic hepatitis C Virus RNA replication. J Virol 2002, 76: 13001-13014. 10.1128\/JVI.76.24.13001-13014.2002","journal-title":"J Virol"},{"key":"2317_CR58","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1128\/JVI.79.5.2689-2699.2005","volume":"79","author":"R Sumpter Jr","year":"2005","unstructured":"Sumpter R Jr, Loo Y-M, Foy E, Li K, Yoneyama M, Fujita T, Lemon SM, Gale M Jr: Regulating intracellular antiviral defense and permissiveness to hepatitis C Virus RNA replication through a cellular RNA Helicase, RIG-I. J Virol 2005, 79: 2689-2699. 10.1128\/JVI.79.5.2689-2699.2005","journal-title":"J Virol"},{"key":"2317_CR59","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/ng1173","volume":"34","author":"AJ Bridge","year":"2003","unstructured":"Bridge AJ, Pebernard S, Ducraux A, Nicoulaz AL, Iggo R: Induction of an interferon response by RNAi vectors in mammalian cells. Nat Genet 2003, 34: 263-264. 10.1038\/ng1173","journal-title":"Nat Genet"},{"key":"2317_CR60","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nbt940","volume":"22","author":"DH Kim","year":"2004","unstructured":"Kim DH, Longo M, Han Y, Lundberg P, Cantin E, Rossi JJ: Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat Biotechnol 2004, 22: 321-325. 10.1038\/nbt940","journal-title":"Nat Biotechnol"},{"key":"2317_CR61","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1017\/S0029665110000108","volume":"69","author":"P Kelly","year":"2010","unstructured":"Kelly P: Nutrition, intestinal defence and the microbiome. Proc Nutr Soc 2010, 69: 261-268. 10.1017\/S0029665110000108","journal-title":"Proc Nutr Soc"},{"key":"2317_CR62","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/jn\/136.5.1365","volume":"136","author":"KZ Long","year":"2006","unstructured":"Long KZ, Estrada-Garcia T, Rosado JL, Ignacio Santos J, Haas M, Firestone M, Bhagwat J, Young C, DuPont HL, Hertzmark E, Nanthakumar NN: The effect of vitamin A supplementation on the intestinal immune response in Mexican children is modified by pathogen infections and diarrhea. J Nutr 2006, 136: 1365-1370.","journal-title":"J Nutr"},{"key":"2317_CR63","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1086\/508292","volume":"194","author":"KZ Long","year":"2006","unstructured":"Long KZ, Santos JI, Rosado JL, Lopez-Saucedo C, Thompson-Bonilla R, Abonce M, DuPont HL, Hertzmark E, Estrada-Garcia T: Impact of vitamin A on selected gastrointestinal pathogen infections and associated diarrheal episodes among children in Mexico City, Mexico. J Infect Dis 2006, 194: 1217-1225. 10.1086\/508292","journal-title":"J Infect Dis"},{"key":"2317_CR64","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1086\/521195","volume":"196","author":"KZ Long","year":"2007","unstructured":"Long KZ, Garcia C, Santos JI, Rosado JL, Hertzmark E, Dupont HL, Ko G: Vitamin A supplementation has divergent effects on norovirus infections and clinical symptoms among Mexican children. J Infect Dis 2007, 196: 978-985. 10.1086\/521195","journal-title":"J Infect Dis"},{"key":"2317_CR65","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0083-6729(06)75013-0","volume":"75","author":"S Mehta","year":"2007","unstructured":"Mehta S, Fawzi W: Effects of vitamins, including vitamin A, on HIV\/AIDS patients. Vitam Horm 2007, 75: 355-383.","journal-title":"Vitam Horm"},{"key":"2317_CR66","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3945\/ajcn.2010.29339","volume":"92","author":"E Villamor","year":"2010","unstructured":"Villamor E, Koulinska IN, Aboud S, Murrin C, Bosch RJ, Manji KP, Fawzi WW: Effect of vitamin supplements on HIV shedding in breast milk. Am J Clin Nutr 2010, 92: 881-886. 10.3945\/ajcn.2010.29339","journal-title":"Am J Clin Nutr"},{"key":"2317_CR67","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.4049\/jimmunol.148.8.2539","volume":"148","author":"JA Turpin","year":"1992","unstructured":"Turpin JA, Vargo M, Meltzer MS: Enhanced HIV-1 replication in retinoid-treated monocytes: Retinoid effects mediated through mechanisms related to cell differentiation and to a direct transcriptional action on viral gene expression. J Immunol 1992, 148: 2539-2546.","journal-title":"J Immunol"},{"key":"2317_CR68","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.1128\/JVI.72.7.5862-5869.1998","volume":"72","author":"JW Maciaszek","year":"1998","unstructured":"Maciaszek JW, Coniglio SJ, Talmage DA, Viglianti GA: Retinoid-induced repression of human immunodeficiency virus type 1 core promoter activity inhibits virus replication. J Virol 1998, 72: 5862-5869.","journal-title":"J Virol"},{"key":"2317_CR69","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1478-3231.2007.01666.x","volume":"28","author":"WO Bocher","year":"2008","unstructured":"Bocher WO, Wallasch C, Hohler T, Galle PR: All-trans retinoic acid for treatment of chronic hepatitis C. Liver Int 2008, 28: 347-354. 10.1111\/j.1478-3231.2007.01666.x","journal-title":"Liver Int"},{"key":"2317_CR70","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1067\/mlc.2003.8","volume":"141","author":"S Hamamoto","year":"2003","unstructured":"Hamamoto S, Fukuda R, Ishimura N, Rumi MA, Kazumori H, Uchida Y, Kadowaki Y, Ishihara S, Kinoshita Y: 9-cis retinoic acid enhances the antiviral effect of interferon on hepatitis C virus replication through increased expression of type I interferon receptor. J Lab Clin Med 2003, 141: 58-66. 10.1067\/mlc.2003.8","journal-title":"J Lab Clin Med"},{"key":"2317_CR71","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1158\/1940-6207.CAPR-09-0239","volume":"3","author":"EM Siegel","year":"2010","unstructured":"Siegel EM, Salemi JL, Craft NE, Villa LL, Ferenczy AS, Franco EL, Giuliano AR: No association between endogenous retinoic acid and human papillomavirus clearance or incident cervical lesions in Brazilian women. Cancer Prev Res 2010, 3: 1007-1014. 10.1158\/1940-6207.CAPR-09-0239","journal-title":"Cancer Prev Res"},{"key":"2317_CR72","volume-title":"Cochrane Database Syst Rev","author":"H Chen","year":"2008","unstructured":"Chen H, Zhuo Q, Yuan W, Wang J, Wu T: Vitamin A for preventing acute lower respiratory tract infections in children up to seven years of age. Cochrane Database Syst Rev 2008. CD006090"},{"key":"2317_CR73","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1067\/mpd.2003.116","volume":"142","author":"I Grotto","year":"2003","unstructured":"Grotto I, Mimouni M, Gdalevich M, Mimouni D: Vitamin A supplementation and childhood morbidity from diarrhea and respiratory infections: a meta-analysis. J Pediatr 2003, 142: 297-304. 10.1067\/mpd.2003.116","journal-title":"J Pediatr"},{"key":"2317_CR74","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1097\/00006454-199609000-00008","volume":"15","author":"JS Bresee","year":"1996","unstructured":"Bresee JS, Fischer M, Dowell SF, Johnston BD, Biggs VM, Levine RS, Lingappa JR, Keyserling HL, Petersen KM, Bak JR, et al.: Vitamin A therapy for children with respiratory syncytial virus infection: a multicenter trial in the United States. Pediatr Infect Dis J 1996, 15: 777-782. 10.1097\/00006454-199609000-00008","journal-title":"Pediatr Infect Dis J"},{"key":"2317_CR75","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0165-2427(91)90039-F","volume":"28","author":"SR Sijtsma","year":"1991","unstructured":"Sijtsma SR, Rombout JH, Dohmen MJ, West CE, van der Zijpp AJ: Effect of vitamin A deficiency on the activity of macrophages in Newcastle disease virus-infected chickens. Vet Immunol Immunopathol 1991, 28: 17-27. 10.1016\/0165-2427(91)90039-F","journal-title":"Vet Immunol Immunopathol"},{"key":"2317_CR76","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/jn\/119.6.940","volume":"119","author":"SR Sijtsma","year":"1989","unstructured":"Sijtsma SR, West CE, Rombout JH, Van der Zijpp AJ: Effect of Newcastle disease virus infection on vitamin A metabolism in chickens. J Nutr 1989, 119: 940-947.","journal-title":"J Nutr"},{"key":"2317_CR77","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/jn\/119.6.932","volume":"119","author":"SR Sijtsma","year":"1989","unstructured":"Sijtsma SR, West CE, Rombout JH, Van der Zijpp AJ: The interaction between vitamin A status and Newcastle disease virus infection in chickens. J Nutr 1989, 119: 932-939.","journal-title":"J Nutr"},{"key":"2317_CR78","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1093\/jn\/137.8.1916","volume":"137","author":"C Rodeheffer","year":"2007","unstructured":"Rodeheffer C, von Messling V, Milot S, Lepine F, Manges AR, Ward BJ: Disease manifestations of canine distemper virus infection in ferrets are modulated by vitamin A status. J Nutr 2007, 137: 1916-1922.","journal-title":"J Nutr"},{"key":"2317_CR79","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1126\/science.2218545","volume":"250","author":"R Blomhoff","year":"1990","unstructured":"Blomhoff R, Green MH, Berg T, Norum KR: Transport and storage of vitamin A. Science 1990, 250: 399-404. 10.1126\/science.2218545","journal-title":"Science"},{"key":"2317_CR80","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/1743-422X-8-224","volume":"13","author":"NH Rosas-Murrieta","year":"2011","unstructured":"Rosas-Murrieta NH, Santos-L\u00f3pez G, Reyes-Leyva J, Jurado FS, Herrera-Camacho I: Modulation of apoptosis by V protein mumps virus. Virol J 2011, 13: 224.","journal-title":"Virol J"},{"issue":"9","key":"2317_CR81","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1089\/jir.2009.0071","volume":"29","author":"S Goodbourn","year":"2009","unstructured":"Goodbourn S, Randall RE: The regulation of type I interferon production by paramyxoviruses. J Interferon Cytokine Res 2009 Sep,29(9):539-547. 10.1089\/jir.2009.0071","journal-title":"J Interferon Cytokine Res"},{"key":"2317_CR82","doi-asserted-by":"publisher","first-page":"11152","DOI":"10.1128\/JVI.01375-10","volume":"84","author":"A Ramachandran","year":"2010","unstructured":"Ramachandran A, Horvath CM: Dissociation of paramyxovirus interferon evasion activities: universal and virus-specific requirements for conserved V protein amino acids in MDA5 interference. J Virol 2010, 84: 11152-11163. 10.1128\/JVI.01375-10","journal-title":"J Virol"},{"key":"2317_CR83","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1099\/vir.0.037531-0","volume":"93","author":"MJ Killip","year":"2012","unstructured":"Killip MJ, Young DF, Precious BL, Goodbourn S, Randall RE: Activation of the beta interferon promoter by paramyxoviruses in the absence of virus protein synthesis. J Gen Virol 2012, 93: 299-307. 10.1099\/vir.0.037531-0","journal-title":"J Gen Virol"},{"issue":"7","key":"2317_CR84","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1128\/JVI.06405-11","volume":"86","author":"K Childs","year":"2012","unstructured":"Childs K, Randall R, Goodbourn S: Paramyxovirus V proteins interact with the RNA Helicase LGP2 to inhibit RIG-I-dependent interferon induction. J Virol 2012 Apr,86(7):3411-3421. 10.1128\/JVI.06405-11","journal-title":"J Virol"},{"key":"2317_CR85","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.immuni.2006.08.007","volume":"25","author":"DB Stetson","year":"2006","unstructured":"Stetson DB, Medzhitov R: Type I interferons in host defense. Immunity 2006, 25: 373-381. 10.1016\/j.immuni.2006.08.007","journal-title":"Immunity"},{"key":"2317_CR86","doi-asserted-by":"publisher","first-page":"9742","DOI":"10.1074\/jbc.272.15.9742","volume":"272","author":"X Weihua","year":"1997","unstructured":"Weihua X, Kolla V, Kalvakolanu DV: Modulation of interferon action by Retinoids: induction of murine stat1 gene expression by retinoic acid. J Biol Chem 1997, 272: 9742-9748. 10.1074\/jbc.272.15.9742","journal-title":"J Biol Chem"},{"key":"2317_CR87","volume-title":"Measles Virus (Rubeola)","author":"S Chabot","year":"2002","unstructured":"Chabot S, Ward BJ: Measles Virus (Rubeola). Philadelphia, PA: Lippincott, Williams and Wilkins; 2002."},{"key":"2317_CR88","first-page":"1","volume-title":"Cochrane Database Syst Rev","author":"J Ni","year":"2005","unstructured":"Ni J, Wei J, Wu T: Vitamin A for non-measles pneumonia in children. Cochrane Database Syst Rev 2005, 1-43. (CD003700)"},{"key":"2317_CR89","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/135965350801300205","volume":"13","author":"E Caselli","year":"2008","unstructured":"Caselli E, Galvan M, Santoni F, Alvarez S, de Lera AR, Ivanova D, Gronemeyer H, Caruso A, Guidoboni M, Cassai E, et al.: Retinoic acid analogues inhibit human herpesvirus 8 replication. Antivir Ther 2008, 13: 199-209.","journal-title":"Antivir Ther"},{"key":"2317_CR90","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/BF01863914","volume":"162","author":"G K\u00e4rber","year":"1931","unstructured":"K\u00e4rber G: Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Naunyn Schmiedebergs Arch Pharmacol 1931, 162: 480-483. 10.1007\/BF01863914","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2317_CR91","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0166-0934(01)00316-0","volume":"96","author":"DD LaBarre","year":"2001","unstructured":"LaBarre DD, Lowy RJ: Improvements in methods for calculating virus titer estimates from TCID50 and plaque assays. J Virol Methods 2001, 96: 107-126. 10.1016\/S0166-0934(01)00316-0","journal-title":"J Virol Methods"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-10-337.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1743-422X-10-337\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-10-337.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T13:43:41Z","timestamp":1688651021000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-10-337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,14]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2317"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-10-337","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,14]]},"assertion":[{"value":"4 January 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"337"}}